Clinical-stage biotech developing oral therapies for rare endocrine diseases.
Industry: Health Care
First Day Return: +44.2%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 06/22/2018 |
Offer Price | $17.00 |
Price Range $15.00 - $17.00 | |
Offer Shares (mm) | 6.0 |
Deal Size ($mm) | $102 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 07/17/2018 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $102 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | San Diego, CA, United States |
Founded | 2008 |
Employees at IPO | 34 |
Website www.crinetics.com |